Lantibiotic resistance

Microbiology and Molecular Biology Reviews : MMBR
Lorraine A DraperR Paul Ross

Abstract

The dramatic rise in the incidence of antibiotic resistance demands that new therapeutic options will have to be developed. One potentially interesting class of antimicrobials are the modified bacteriocins termed lantibiotics, which are bacterially produced, posttranslationally modified, lanthionine/methyllanthionine-containing peptides. It is interesting that low levels of resistance have been reported for lantibiotics compared with commercial antibiotics. Given that there are very few examples of naturally occurring lantibiotic resistance, attempts have been made to deliberately induce resistance phenotypes in order to investigate this phenomenon. Mechanisms that hinder the action of lantibiotics are often innate systems that react to the presence of any cationic peptides/proteins or ones which result from cell well damage, rather than being lantibiotic specific. Such resistance mechanisms often arise due to altered gene regulation following detection of antimicrobials/cell wall damage by sensory proteins at the membrane. This facilitates alterations to the cell wall or changes in the composition of the membrane. Other general forms of resistance include the formation of spores or biofilms, which are a common mechanistic resp...Continue Reading

References

Dec 1, 1991·Applied and Environmental Microbiology·K A StevensT R Klaenhammer
Jan 1, 1988·Advances in Microbial Physiology·W Fischer
Feb 21, 1967·Biochemical and Biophysical Research Communications·R M Gould, W J Lennarz
Apr 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·W J LennarzJ Reiss
Dec 1, 1983·Applied and Environmental Microbiology·K RaymanA Hurst
Sep 1, 1984·Journal of General Microbiology·M R NahaieV Hájek
Jun 1, 1981·Microbiological Reviews·J B Ward
Feb 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E T RietschelF Di Padova
Dec 1, 1993·Journal of Bacteriology·S A BoylanC W Price
Aug 1, 1995·Protein Science : a Publication of the Protein Society·K C KeilerR T Sauer
Feb 2, 1996·The Journal of Biological Chemistry·K C Keiler, R T Sauer
Dec 1, 1995·Antimicrobial Agents and Chemotherapy·M L ChikindasP W Caufield
Feb 1, 1996·Antonie van Leeuwenhoek·G N MollA J Driessen
Sep 18, 1997·Applied and Environmental Microbiology·A VerheulT Abee
Jan 22, 1998·Applied and Environmental Microbiology·A D Crandall, T J Montville
Feb 4, 1998·Antimicrobial Agents and Chemotherapy·H BrötzH G Sahl
Dec 5, 1998·Microbiology and Molecular Biology Reviews : MMBR·C Goffin, J M Ghuysen
Jan 30, 1999·Applied and Environmental Microbiology·U PagH G Sahl
Jul 17, 1999·International Journal of Systematic Bacteriology·W Fischer, K Leopold
Feb 29, 2000·Biochimica Et Biophysica Acta·R P Huijbregts de Kruijff B
Jun 17, 2000·FEMS Microbiology Letters·M T MataJ C Pérez-Díaz
Sep 6, 2000·Letters in Applied Microbiology·I S Boziaris, M R Adams

❮ Previous
Next ❯

Citations

Feb 24, 2016·Frontiers in Cell and Developmental Biology·Liang ZhouOscar P Kuipers
Oct 6, 2015·Journal of Molecular Biology·Michele LeRouxJoseph D Mougous
Apr 20, 2016·Frontiers in Microbiology·Guyue ChengZonghui Yuan
Apr 20, 2016·Frontiers in Microbiology·Kevin EganPaul D Cotter
Dec 19, 2015·Journal of Applied Microbiology·J M ShinY L Kapila
Aug 3, 2016·Probiotics and Antimicrobial Proteins·Djamel DriderMichael L Chikindas
Sep 4, 2016·FEMS Microbiology Reviews·Manuel Montalbán-LópezOscar P Kuipers
Dec 19, 2015·PLoS Pathogens·Dirk-Jan Scheffers, Menno B Tol
Aug 17, 2016·Scientific Reports·Abdelahhad BarbourKoshy Philip
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Anton Du Preez van StadenLeon M T Dicks
Feb 21, 2018·Nature Chemistry·Jani Reddy BollaCarol V Robinson
Mar 6, 2019·Infection and Immunity·Chance J CosgriffFrancis Alonzo
May 9, 2019·Future Microbiology·Aimee Rp Tierney, Philip N Rather
Jun 5, 2020·FEMS Microbiology Reviews·Beatriz MartínezMarie-Pierre Chapot-Chartier
Jul 15, 2017·Frontiers in Microbiology·Harsh MathurR Paul Ross
Jun 13, 2018·Frontiers in Microbiology·Nicholas P GreeneVassilis Koronakis
Jul 3, 2018·Frontiers in Microbiology·Ronan GoughMary C Rea
Aug 1, 2020·Frontiers in Cellular and Infection Microbiology·Tingjun LiuLihong Guo
Jan 12, 2017·Toxins·Alessandra F PernaDiego Ingrosso
Dec 3, 2017·Expert Opinion on Drug Discovery·Mengxin Geng, Leif Smith
Feb 7, 2018·Frontiers in Molecular Biosciences·Rebecca ClemensSander H J Smits
Aug 16, 2019·Pharmaceutical Research·Anastasiia B ShatanDaniel Horák
Sep 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hiroshi Ogawara
Apr 5, 2018·Frontiers in Microbiology·Johan A KersMartin Handfield
Feb 1, 2019·Scientific Reports·Marcel LagedrosteLutz Schmitt
Apr 2, 2020·Journal of Bacteriology·Delphine DufourCéline M Lévesque
Oct 13, 2015·Acta Crystallographica. Section F, Structural Biology Communications·Sakshi KhosaSander H J Smits
Oct 12, 2020·FEBS Letters·Sander H J SmitsKonstantinos Beis
Nov 10, 2020·Frontiers in Microbiology·Ricardo Sánchez de la NietaMargarita Díaz
Dec 17, 2020·Frontiers in Microbiology·Jerzy KarczewskiStephen J Streatfield
Jul 25, 2019·Bioorganic & Medicinal Chemistry·Julia Zaschke-KriescheSander H J Smits
Dec 1, 2020·Frontiers in Microbiology·Hamid Reza Karbalaei-Heidari, Nediljko Budisa
Apr 21, 2017·Emerging Topics in Life Sciences·Kevin EganColin Hill
Mar 4, 2020·Biochimica Et Biophysica Acta. Biomembranes·Xiaoqi WangEefjan Breukink
Mar 11, 2021·Critical Reviews in Microbiology·Ana Andréa Teixeira BarbosaSilvio Santana Dolabella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.